Workshop report213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015

- The phenotypes of the idiopathic inflammatory myopathies (IIM) are discussed.
- The inclusion criteria for future clinical trials for IIM are discussed.
- The evaluation of muscle weakness and function in patients with IIM is discussed.
- Consensus in outcome measures for use in IIM clinical trials was reached.
- The evaluation of quality of life for IIM is discussed.